AdaptHealth Corp. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by AdaptHealth Corp. (AHCO) on January 12, 2021, reporting events occurring on January 5, 2021. The filing details a secondary offering and primary issuance of Class A Common Stock.
Key Financial Metrics
The filing text does not provide specific revenue, profit, cash flow, margin, debt, or liquidity figures. The document focuses exclusively on the terms of a capital raising transaction.
Material Changes and Transaction Details
On January 5, 2021, the Company entered into an underwriting agreement with Deutsche Bank Securities Inc. and Jefferies LLC. The transaction involved:
- Primary Offering: The Company sold 7,250,000 shares of Class A Common Stock.
- Secondary Offering: A Selling Stockholder sold 750,000 shares of Class A Common Stock.
- Over-Allotment Option: The underwriters exercised their option in full to purchase an additional 1,200,000 shares from the Company.
- Total New Issuance: The Company issued a total of 8,450,000 new shares of Class A Common Stock.
The offering was conducted pursuant to an effective shelf registration statement on Form S-3.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, or outlook for future periods. It notes customary representations, warranties, indemnification obligations, and termination provisions within the Underwriting Agreement. The legality of the issuance was confirmed by an opinion from Willkie Farr & Gallagher LLP.
Key Facts for Investor Verification
- Verify the total number of new shares issued (8,450,000) and the resulting dilution impact on existing shareholders.
- Confirm the use of proceeds from the primary offering, which is not detailed in this specific 8-K text.
- Review the full Underwriting Agreement (Exhibit 1.1) for specific pricing, underwriting discounts, and lock-up provisions.
- Check subsequent filings for the final closing date and actual cash proceeds received.